Dopamine Receptors – DRD2 Genetic Testing (Taq1A, -141C Ins/Del)

Product detailed description

Dopamine receptor genetic testing identifies inherited genetic variants associated with the dopamine system, which plays an important role in motivation, reward processing, learning, and behavioral regulation. Dopamine is a neurotransmitter that enables communication between nerve cells and contributes to numerous processes involved in everyday brain function.

The test analyzes two genetic variants: Taq1A (rs1800497) and -141C Ins/Del (rs1799732). These variants have been investigated in relation to dopamine D2 receptors, which are involved in transmitting dopamine signals in the brain.

The Taq1A variant is located in the ANKK1 gene near DRD2 and has been associated in some studies with differences in dopamine D2 receptor availability. The -141C Ins/Del variant is located in a regulatory region of the DRD2 gene, although its functional significance remains under investigation.

What does the genetic test analyze?

• Dopamine signaling – genetic variants studied in relation to dopamine D2 receptor function.

• Motivation and reward processing – genetic factors investigated in relation to brain pathways involved in motivation and reward.

• Learning and behavioral regulation – potential associations between genetic variation and dopamine-related neural processes.

• Individual differences in dopamine signaling – genetic characteristics studied for their possible influence on dopamine receptor biology.

Who may benefit from dopamine receptor genetic testing?

• Individuals interested in the genetics of motivation, reward processing, and behavior.

• People interested in neuroscience, neurogenetics, and dopamine signaling.

• Those seeking to better understand selected genetic variants associated with dopamine D2 receptors.

• Anyone interested in genetic factors related to nervous system function.

What can the results reveal?

The dopamine receptor DNA test identifies the tested Taq1A and -141C Ins/Del variants. Results provide additional information about genetic differences being studied in relation to dopamine signaling and D2 receptor availability or regulation.

Important: Genetic test results cannot determine dopamine levels in the brain, personality, motivation, or an individual's risk of addiction or psychiatric disorders. Associations between these variants and behavior are complex, and much of the evidence remains insufficient for clinical prediction. This test is primarily informational and does not replace neurological or psychiatric assessment.